We utilized our photoconjugation strategy to directly couple both Gx-LB and Gx-SB to three important clinical therapeutic antibodies: cetuximab which targets EGFR and is used for colorectal cancer treatment41, and adalimumab and infliximab which target TNFα and are prescribed for a variety of autoimmune diseases42 (Fig. 4a and Supplementary Fig. 21). The gene discussed is TNF; the disease is colorectal cancer.